Cargando…
Insights in Anaphylaxis and Clonal Mast Cell Disorders
The prevalence of anaphylaxis among patients with clonal mast cell disorders (MCD) is clearly higher comparing to the general population. Due to a lower frequency of symptoms outside of acute episodes, clonal MCD in the absence of skin lesions might sometimes be difficult to identify which may lead...
Autores principales: | González-de-Olano, David, Álvarez-Twose, Iván |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502410/ https://www.ncbi.nlm.nih.gov/pubmed/28740494 http://dx.doi.org/10.3389/fimmu.2017.00792 |
Ejemplares similares
-
Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis
por: Elst, Jessy, et al.
Publicado: (2022) -
Recent advances in mast cell clonality and anaphylaxis
por: Akin, Cem
Publicado: (2009) -
The Mast Cell, Contact, and Coagulation System Connection in Anaphylaxis
por: Guilarte, Mar, et al.
Publicado: (2017) -
Safety of COVID-19 vaccination in patients with clonal mast cell disorders
por: Ruano-Zaragoza, Maria, et al.
Publicado: (2022) -
Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes
por: González-de-Olano, David, et al.
Publicado: (2016)